Clinical Trial Update: A Trial Using Double-Bolus THR-100 Versus Streptokinase [Phase 3]

View source ↗

Summary

Phase 3 trial comparing double-bolus THR-100 with Streptokinase in acute myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Streptokinase (streptokinase)
• THR-100 (THR-100)

Snippet

Sponsor: Bharat Biotech International Limited | Conditions: Acute Myocardial Infarction | Phase 3 | Status: COMPLETED